Can Hepatitis B e Antigen Turn Negative Without Treatment? - Gastroenterology and Hepatology

Share to:

Regarding e antigen?


Is it possible for the e antigen to become negative without pharmacological treatment?

gladylei, 30~39 year old female. Ask Date: 2012/08/06

Dr. Chen Shidian reply Gastroenterology and Hepatology


Hello Gladylei, the E antigen is a protein produced by the virus.
As the patient's immune system strengthens, it suppresses the virus or the virus may mutate, leading to a loss of the ability to produce the E antigen.
This can result in a negative E antigen status.
However, it is still necessary to check the DNA of the virus to make a proper distinction.
Changhua Hospital cares about your health.
Dr.
Chen Shidian.

Reply Date: 2012/08/06

More Info


Hepatitis B e Antigen (HBeAg) positivity indicates active viral replication and a higher likelihood of liver inflammation. In some cases, HBeAg can turn negative without specific antiviral treatment, but this is not the norm and typically occurs in certain circumstances.
The transition from HBeAg positive to negative can happen spontaneously in some individuals, particularly in those with chronic Hepatitis B infection. This phenomenon is often referred to as "spontaneous HBeAg seroconversion." Factors that may contribute to this include the host's immune response, the viral strain, and the overall health of the liver.
In general, spontaneous seroconversion is more common in younger patients and those with a less severe form of the disease. Studies suggest that about 20-30% of patients with chronic Hepatitis B may experience spontaneous HBeAg seroconversion over a period of several years. However, this process can be unpredictable and is not guaranteed.

When HBeAg turns negative, it is often accompanied by the appearance of antibodies to the e antigen (anti-HBe), which indicates that the immune system has mounted a response against the virus. This transition is generally considered a positive sign, as it often correlates with a decrease in viral replication and an improvement in liver function. However, it is essential to monitor the patient closely, as some individuals may still have detectable Hepatitis B virus (HBV) DNA in their blood, indicating ongoing viral activity.

In the absence of treatment, the likelihood of HBeAg turning negative is relatively low, especially in patients with high viral loads and significant liver inflammation. Antiviral medications, such as nucleos(t)ide analogs (like entecavir or tenofovir), are often recommended to help suppress viral replication and promote seroconversion. These medications can effectively reduce liver inflammation and improve liver function, leading to better long-term outcomes.

In conclusion, while it is possible for HBeAg to turn negative without treatment, it is not common and typically occurs in specific patient populations. For most individuals with chronic Hepatitis B, antiviral therapy is the most effective way to achieve HBeAg seroconversion and improve liver health. Regular monitoring of liver function and viral load is crucial in managing the disease and determining the appropriate treatment strategy. If you are concerned about your Hepatitis B status or treatment options, it is essential to consult with a healthcare provider specializing in liver diseases for personalized advice and management.

Similar Q&A

Understanding Negative E Antigen and Antibody Results in Hepatitis B

Hello Dr. Chen, I am a hepatitis B patient. This month, my tests for hepatitis B e-antigen (HBeAg) and hepatitis B e-antibody (anti-HBe) were both negative. Does this mean I have recovered?


Dr. Chen Shidian reply Gastroenterology and Hepatology
It is likely due to the natural attenuation of the virus or the suppressive effects of antiviral medications. Most of the virus still exists within liver cells, leading to a state of coexistence, and regular monitoring is still necessary.

[Read More] Understanding Negative E Antigen and Antibody Results in Hepatitis B


Understanding Hepatitis B: Transmission Risks and Vaccine Efficacy

I have been infected with hepatitis B for over 2 years. My surface antigen is still positive, and last week my E antigen test was negative. Does this mean I am completely non-infectious to others? If I receive the hepatitis B vaccine now, can it produce hepatitis B surface antibo...


Dr. Li Xuanshu reply Gastroenterology and Hepatology
Hello! Your test results show that the e antigen is negative, which indicates that the viral activity is low and the infectiousness is relatively low, making it less likely to transmit to others. You are already a hepatitis B patient, and receiving the vaccine will be ineffective...

[Read More] Understanding Hepatitis B: Transmission Risks and Vaccine Efficacy


Understanding e Antigen: Implications of Its Absence and Benefits of Its Presence

What does the absence of the e antigen indicate? What are the benefits if the e antigen is produced?


Dr. Chen Shidian reply Gastroenterology and Hepatology
Hello everyone: A positive reaction for e-antigen indicates strong activity of the hepatitis B virus, while a negative result generally suggests low toxicity and a reduced risk of progression to cirrhosis (though there are exceptions). Wishing you all good health!

[Read More] Understanding e Antigen: Implications of Its Absence and Benefits of Its Presence


Understanding Hepatitis B e Antibody: Treatment Outcomes and Longevity

Hello Dr. Lin, I would like to ask you: If after taking antiviral medication for six months, the blood test shows e-antibody <1, but the e-antigen is still positive and the viral load is undetectable, does this still indicate that the patient is not cured? Additionally, will t...


Dr. Lin Minghui reply Gastroenterology and Hepatology
1. In chronic hepatitis B patients who are e-antigen positive and have liver enzyme levels more than twice the normal limit, after six months of antiviral medication, if the viral load is undetectable, it cannot be considered a cure. The treatment goal is to continue until e-anti...

[Read More] Understanding Hepatitis B e Antibody: Treatment Outcomes and Longevity


Related FAQ

Hepatitis B Antibodies

(Gastroenterology and Hepatology)

Hepatitis B Infection Risk

(Gastroenterology and Hepatology)

E Antigen

(Gastroenterology and Hepatology)

Hepatitis B Vaccine

(Gastroenterology and Hepatology)

Hepatitis B Screening

(Gastroenterology and Hepatology)

Hepatitis B Transmission

(Gastroenterology and Hepatology)

Hepatitis B Medication

(Gastroenterology and Hepatology)

B

(Gastroenterology and Hepatology)

Defecation

(Gastroenterology and Hepatology)

Hepatitis C Infection Risk

(Gastroenterology and Hepatology)